Tech refresh Compute Services infrastructure (ServerDatabaseStorage and Bakcup) .note

Source: /Volumes/X9 Pro/ObsNotes/YoudaoYunNotes/Tech refresh Compute Services infrastructure (ServerDatabaseStorage and Bakcup) .note.pdf Converted: 2025-12-10 12:17:11

---

Tech refresh Compute Services infrastructure (Server/Database/Storage and Bakcup) at Boulder site

to modernize infrastructure and better enable more standard compute services. Move as much

Compute Services (server maintenance, monitoring, anti-virus, back-up, problem resolution and tech

refresh) at Boulder site to Agilent IT support model.

Migrate Non-GMP standard business applications (as applicable) and personal/group file shares to

COS and standard IT solutions.

Setup CS Infrasructure at Boulder, it will include ESX VM Hosts and physical servers (as needed),

NetApp Filer (Shared Storage) and DataDomain (Backup) to accommodate GMPSystems and NASD

specific systems which need to remain local

Tech refresh the existing Boulder infrastructure to modernize infrastructure and enable standard

computing services.

Allow local IT team to focus more on NASD-specific applications and to make IT services at NASD

more effective and efficient

The Nucleic Acid Solutions Division, or NASD, is a contract manufacturer whose clients are building a

new class of pharmaceutical therapies.NASD business model is different from other divisions. They

have only 2-3 orders/shipments per month, very few customers, and all products are custom contract

manufacturing deals (80%) or contract Time and Material R&D work.

Our investment in NASD dates back to 2006. In the 10 years since, the pharma industry has

continued to invest in nucleic-acid-based drugs, and the demand for NASD’s services has increased

accordingly. We nearly tripled our revenue in the last five years, and we expect continued growth for

at least the next few years.Boulder is the most densely compacted

That’s why we’re expanding the site. We’re building out the facilities now, and preserving the ability to

grow even more in the future.

Our nucleic-acid solution division, or NASD, is in Boulder, Colo. A few months ago we bought 20

acres of vacant land in Frederick, a rural town about 30 minutes east of Boulder. Our short-term plan

is to build a second manufacturing suite there, which would double the capacity currently available in

Boulder. We’ll still have room to build a third, fourth and fifth suite as market forces demand additional

capacity.. We expect it to be online and producing commercial pharmaceuticals by Q1 of FY19.